Chemical formula: C₂₁H₂₃N₃OS Molecular mass: 365.492 g/mol PubChem compound: 4747
Pericyazine is a neuroleptic with cardiovascular and antihistamine effects similar to those of chlorpromazine, but it has a stronger antiserotonin effect and a powerful central sedative effect.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05AC01 | Periciazine | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AC Phenothiazines with piperidine structure |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| PERICYAZINE Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Periciazine is an active ingredient of these brands:
Australia (AU)Brazil (BR)Canada (CA)Estonia (EE)France (FR)Hong Kong (HK)Japan (JP)Netherlands (NL)New Zealand (NZ)Spain (ES)Tunisia (TN)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
